Prostate Cancer
Cancer that forms in the prostate. NCI PDQ covers detection, grading/staging concepts, and treatment overviews.
Catalog review date: Oct 31, 2025
Suggested registry condition query: prostate cancer
Overview
Patient-friendly
Prostate cancer is common and often grows slowly, but not always. NCI patient pages explain terms and questions to discuss with a clinician.
Professional
Risk stratification frameworks are summarized in NCI PDQ—consult primary sources for details.
Sources
- NCI Prostate Cancer · National Cancer Institute (NCI) PDQ — Patient · retrieved Nov 13, 2025 · reviewed Oct 31, 2025
Diagnosis and pathology
Patient-friendly
PSA testing, imaging, and biopsy may be part of evaluation. Pathology grades help describe aggressiveness—your team explains what applies to you.
Professional
Gleason / Grade Group reporting and diagnostic pathways: NCI HP PDQ.
Sources
- Prostate HP PDQ · National Cancer Institute (NCI) PDQ — Health Professional · retrieved Nov 13, 2025 · reviewed Oct 31, 2025
Staging and biomarkers
Patient-friendly
Stage and other test results guide conversations about monitoring versus active treatment.
Professional
Genomic and imaging biomarkers: refer to NCI PDQ and primary literature; not interpreted here.
Sources
- Patient PDQ · National Cancer Institute (NCI) PDQ — Patient · retrieved Nov 13, 2025 · reviewed Oct 31, 2025
General treatment approaches
Patient-friendly
Options can include active surveillance, surgery, radiation, hormonal therapy, and other medicines. Shared decision-making with your clinicians is essential.
Professional
Treatment modality evidence tables live in NCI PDQ. No platform treatment recommendations.
Sources
- Patient treatment PDQ · National Cancer Institute (NCI) PDQ — Patient · retrieved Nov 13, 2025 · reviewed Oct 31, 2025
- HP treatment PDQ · National Cancer Institute (NCI) PDQ — Health Professional · retrieved Nov 13, 2025 · reviewed Oct 31, 2025
Relevant clinical trials
Patient-friendly
Search prostate cancer studies via the Trial Explorer. Enrollment must be confirmed with investigators.
Professional
ClinicalTrials.gov is the primary registry source in Phase 1.
Sources
- ClinicalTrials.gov · NIH / NLM · retrieved Nov 13, 2025
Research and approvals
Patient-friendly
Track source-linked updates on the Updates page.
Professional
Phase 2: FDA/NCI/PubMed adapters with change detection.
Sources
- FDA Oncology · U.S. FDA · retrieved Nov 13, 2025
Patient resources
Patient-friendly
NCI prostate cancer materials support patient education and navigating care discussions.
Professional
Prefer authoritative patient education links.
Sources
- NCI Prostate resources · National Cancer Institute (NCI) PDQ — Patient · retrieved Nov 13, 2025 · reviewed Oct 31, 2025
Primary references
- NCI Prostate Cancer hub — National Cancer Institute (NCI) PDQ — Patient
- Prostate cancer treatment (patient PDQ) — National Cancer Institute (NCI) PDQ — Patient
- Prostate cancer treatment (HP PDQ) — National Cancer Institute (NCI) PDQ — Health Professional
External evidence above is distinct from any future platform-authored clinical interpretation (which would require editorial review).